Revenue
2019
2020
2021
2022
2023
2024
2025
Alignment Healthcare, Inc. (ALHC)
Price—Loading quote
Net income
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $3.95B | $2.70B | $1.80B | $1.43B | $1.17B | $955.4M | $754.0M |
| Operating expenses | $3.93B | $2.81B | $1.95B | $1.56B | $1.35B | $964.5M | $786.4M |
| Operating income | $14.8M | −$101.6M | −$127.8M | −$128.6M | −$178.1M | −$5.3M | −$29.5M |
| EBITDAderived | $45.2M | −$74.7M | −$106.4M | −$111.4M | −$162.3M | $9.8M | −$14.6M |
| Net income | −$724,000 | −$128.0M | −$148.0M | −$149.5M | −$195.3M | −$22.9M | −$44.7M |
| Basic EPSper diluted share | $0.00 | -$0.67 | -$0.79 | -$0.83 | -$1.14 | -$0.15 | -$0.33 |
| Diluted EPSper diluted share | $0.00 | -$0.67 | -$0.79 | -$0.83 | -$1.14 | -$0.15 | -$0.33 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 26, 2026Form 4 · 10b5-1 | KONOWIECKI JOSEPH SEVP, Corporate Affairs | SellCommon Stock | 25.0K | $23.00 | $575.0K | 1.13M |
| Jun 18, 2026Form 4 · 10b5-1 | KONOWIECKI JOSEPH SEVP, Corporate Affairs | SellCommon Stock | 25.0K | $22.00 | $550.0K | 1.15M |
| Jun 15, 2026Form 4 · 10b5-1 | Maroney Dawn ChristinePresident | SellCommon Stock | 30.0K | $19.55 | $586.5K | 947.3K |
| Jun 12, 2026Form 4 · 10b5-1 | Kim HyongChief Medical Officer | SellCommon Stock | 36.0K | $19.86 | $714.0K | 331.8K |
| Jun 11, 2026Form 4 · 10b5-1 | KONOWIECKI JOSEPH SEVP, Corporate Affairs | SellCommon Stock | 25.0K | $21.00 | $525.0K | 1.18M |